Showing results (1051-1060 of 1,262) with videos related to
Sort By:
Pageof 127
Journal of Cellular Biochemistry|November 25, 2003
Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrixJing-Ping Yun, Eng Ching Chew, Choong-Tsek Liew, et al.Chembiochem : a European Journal of Chemical Biology|June 22, 2013
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressorsHsueh-Yun Lee, Chia-Ron Yang, Mei-Jung Lai, et al.Organic & Biomolecular Chemistry|October 6, 2022
Metal-free visible-light-driven cascade cyclization reaction to synthesize 2-oxindoles via benzoyl and phenylsulfinyl radicals with acrylamide derivativesXin Sun, Jing-Ping Zhu, Qing-Chuang Qiu, et al.Iscience|May 27, 2024
NOT gated T cells that selectively target EGFR and other widely expressed tumor antigensJulyun Oh, Charles Kirsh, Jing-Ping Hsin, et al.European Journal of Medicinal Chemistry|September 20, 2017
1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myelomaYi-Min Liu, Wei-Chun HuangFu, Han-Li Huang, et al.Veterinary Microbiology|July 2, 2020
Molecular characterization and pathogenesis of H9N2 avian influenza virus isolated from a racing pigeonRui-Hua Zhang, Pei-Yao Li, Ming-Ju Xu, et al.The Journal of Biological Chemistry|May 31, 2021
Active site architecture of an acetyl xylan esterase indicates a novel cold adaptation strategyYi Zhang, Hai-Tao Ding, Wen-Xin Jiang, et al.European Journal of Medicinal Chemistry|June 7, 2011
Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agentsMei-Jung Lai, Jang-Yang Chang, Hsueh-Yun Lee, et al.Diabetes Research and Clinical Practice|July 12, 2005
Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in AsiaLee-Ming Chuang, Sidartawan Soegondo, Pradana Soewondo, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cellsJing-Ping Li, Nai-Xia Cao, Ri-Ting Jiang, et al.Pageof 127